BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice

[img]
fpsyg-07-02063.pdf - Published Version (332kB)
Available under license: Creative Commons Attribution

Sorensen, James, Petersen, Aaron ORCID: 0000-0003-1508-748X, Timpani, Cara ORCID: 0000-0003-4567-4319, Campelj, Dean, Cook, Jordan, Trewin, Adam, Stojanovska, Vanesa, Stewart, Mathew, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2017) BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice. Frontiers in Pharmacology, 8. ISSN 1663-9812

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/33163
DOI https://doi.org/10.3389/fphar.2017.00137
Official URL http://journal.frontiersin.org/article/10.3389/fph...
Subjects Historical > FOR Classification > 1116 Medical Physiology
Historical > Faculty/School/Research Centre/Department > Institute of Sport, Exercise and Active Living (ISEAL)
Historical > Faculty/School/Research Centre/Department > Institute for Sustainability and Innovation (ISI)
Current > Division/Research > College of Health and Biomedicine
Keywords skeletal muscle; oxaliplatin chemotherapy; BGP-15; mitochondria; protein synthesis; muscle wasting; mitochondrial reactive oxygen species
Citations in Scopus 20 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login